Tammy Lovell
Silicon Valley Bank report says investment in Europe sky-rocketed in 2020.
The funds will be used to drive European leadership in digital chronic disease prevention and management.
The proceeds will be used to drive product development and expand operations in the US.
The £40 million system is intended to enable researchers to tackle the most pressing medical challenges.
Investment proceeds will primarily fund FDA registration studies and opening of US headquarters.
The EU-backed community of health innovators is funding several projects to promote healthy ageing in Europe.
The funds will support global expansion to meet growing clinical and biopharma demand for data-driven medicine.
The pharma giant is collaborating with sports tech firm Supersapiens.
Funding will enable the company to expand its app for chronic joint pain to the US and further across Europe.
The Virolens system has undergone a successful trial at London’s Heathrow Airport.